Cost-effectiveness analysis of treatment of E. histolytica/E. dispar cyst carriers

Archives of Medical Research

Volumn 28, Issue , 1997, Pages 293-294

  Garduno Espinosa, J ^a   Martinez Garcia, M C ^a   Valadez Salazar, A ^a   Padilla, G ^a   Cedillo Rivera, R ^a   Munoz, O ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

Author keywords

Cost effectiveness analysis; E. dispar; Entamoeba histolytica

Indexed keywords

ANTIPARASITIC AGENT; METRONIDAZOLE;

AMEBIASIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE CARRIER; ENTAMOEBA DISPAR; ENTAMOEBA HISTOLYTICA; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; CARRIER STATE; COST-BENEFIT ANALYSIS; ENTAMOEBA; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; HUMANS; MEXICO; PREVALENCE;

EID: 0031014313     PISSN: 01880128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)